Friday, January 04, 2008
Protox announces positive Phase 1 enlarged-prostate drug study
VANCOUVER - Protox Therapeutics Inc. (TSXV:PRX) has reported a positive Phase 1 study on its PRX302 drug candidate for benign prostatic hyperplasia, a common condition among aging males....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment